Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Zosano Pharma Corp (ZSAN)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsMar-31-22Dec-31-21Sep-30-21Mar-31-21Dec-31-20Sep-30-20Jun-30-20Jun-05-20
   10-Q10-K10-Q10-Q10-K10-Q10-Q8-K
Service revenue     0.30.2   
            Service revenue growth       -25.7%  
Operating expenses:          
Cost of service revenue     0.2    
Research and development     21.421.621.922.6 
General and administrative     10.911.211.712.0 
    Total operating expenses     25.025.317.1  
    Loss from operations     -32.2-32.8-33.6-34.6 
            Operating margin     -12484.5% -680.6%  
   
Other income (expense):          
Interest income     0.00.00.00.1 
Interest expense     -0.6-0.7-0.7-0.8 
Other income (expense), net     0.00.10.10.0 
    Loss before provision for income taxes     -32.8-33.4-26.3-35.4 
    Net loss     -32.8-33.4-34.2-35.4 
   
Net loss per common share - basic (in USD per share)     ($3.02)($0.53)($0.94)($1.38) 
Net loss per common share - diluted (in USD per share)     ($3.02)($0.53)($0.94)($1.38) 
   
Weighted-average common shares used in computing net loss per common share – basic     50.959.246.431.4 
Weighted-average common shares used in computing net loss per common share – diluted     50.959.246.431.4 
   
Revenue from Contract with Customer, Product and Service [Extensible List]          
Cost, Product and Service [Extensible List]          

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy